European congress of EABCT

The 2022 European Congress of the EABCT (European Associations of Behavioral and Cognitive Therapy) has just concluded in Barcelona.

EABCT is the most important umbrella association of cognitive behavioral therapy (CBT). Each and every year different scholars and clinicians meet up and discuss about trends and advances in CBT. During 2020 event several experts such as Todd Farchione, Emily Holmes and others discussed how transdiagnostic approaches are getting more and more relevant in daily practice and research.

Personally I presented the preliminary data of a recently concluded RCT where I teseted a new integrative therapy for schizotypal personality disorder. Evolutionary Systems Therapy for Schizotypy is a new treatment integrating evolutionary approaches, compassion focused therapy and metacognitively oriented psychotherapy. The RCT compared ESTS with a combination of CBT for personality disorders and standard psychopharmacotherapy. The protocol is described in a previous post.

A new RCT on schizotypal personality disorder

RCT on schizotypal personality disorder

Fingers crossed for a recently submitted paper on our randomized controlled trial, RCT, on Schizotypal Personality Disorder!

In the last two years my team and I have dedicated so many efforts to this challange. We have tried to outline and test a new treatment for those diagnosed with Schizotypal Personality Disorder. The intervention was a 6-month therapy compared with a stardard treatment comprising of Cognitive Behavioral Therapy (CBT) for personality disorders plus psychopharmacological treatment. The RCT has been registered on ClinicalTrials.gov and the paper submitted in July.

We defined the intervention as Evolutionary Systems Therapy for Schizotypy (ESTS) since it integrates different approaches: an evolutionary look at schizotypy, a systemic framework in understanding self-to-self and self-to-other relationships, a metacognitively oriented approach to in session conceptualization, and finally a compassion focused approach to experiential tecniques.

The results of our RCT on Schizotypal Personality Disorder

were really good! We confirmed (as desidered and hypothesized) a non superiority of the control group (CBT + drugs) and in the secondary outcomes (metacognitife functioning and general symptomatology) we found a superiority of ESTS.

Preprint of the paper can be read on OSF!